BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $EWTX readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05540860-pcd@datacutoff.com
DTSTAMP:20261118T142521Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:~Sevasemten Dose 1 readout (P2) · Edgewise Therapeutics\, Inc. $EW
 TX
DESCRIPTION:A Study of EDG-5506 in Children With Duchenne Muscular Dystroph
 y (LYNX)\n\nPrimary completion date: 2027-01 (estimated) — month only\, 
 shown on the 1st\nOriginally planned: 2024-06 (+31.0 months)\nPhase 2 · R
 are · Duchenne Muscular Dystrophy\nEnrollment: 76 · Sites: 14\n\nPrimary
  completion = last participant's primary-endpoint data collected\; topline
  results usually follow weeks to months later. Sponsor-reported\, often an
  estimate. Not investment advice.\n\nhttps://datacutoff.com/radar.html?nct
 =NCT05540860\nhttps://clinicaltrials.gov/study/NCT05540860
URL:https://datacutoff.com/radar.html?nct=NCT05540860
CATEGORIES:Rare,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06100887-pcd@datacutoff.com
DTSTAMP:20261118T142521Z
DTSTART;VALUE=DATE:20270301
DTEND;VALUE=DATE:20270302
SUMMARY:~FOX readout (P2) · Edgewise Therapeutics\, Inc. $EWTX
DESCRIPTION:Phase 2 Study of EDG-5506 in Children and Adolescents With Duch
 enne Muscular Dystrophy Previously Treated With Gene Therapy\n\nPrimary co
 mpletion date: 2027-03 (estimated) — month only\, shown on the 1st\nOrig
 inally planned: 2025-06 (+21.0 months)\nPhase 2 · Rare · Duchenne Muscul
 ar Dystrophy\nEnrollment: 43 · Sites: 7\n\nPrimary completion = last part
 icipant's primary-endpoint data collected\; topline results usually follow
  weeks to months later. Sponsor-reported\, often an estimate. Not investme
 nt advice.\n\nhttps://datacutoff.com/radar.html?nct=NCT06100887\nhttps://c
 linicaltrials.gov/study/NCT06100887
URL:https://datacutoff.com/radar.html?nct=NCT06100887
CATEGORIES:Rare,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
